Abeona Therapeutics (NASDAQ:ABEO) reported quarterly losses of $(2.08) per share. This is a 48 percent increase over losses of $(4.00) per share from the same period last year.
Oppenheimer Maintains Outperform on Microsoft, Raises Price Target to $340
Oppenheimer analyst Timothy Horan maintains Microsoft (NASDAQ:MSFT) with a Outperform and raises the price target from $330 to $340.